John Flavin work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
John Flavin personal email
- Valid
John Flavin phone numbers
John is a proven leader with a stellar track record of building valuable corporate, academic and civic enterprises from concept to reality including biotech companies he launched and took public on NASDAQ such as MediChem Life Sciences and Advanced Life Sciences; and civic organizations including Chicago Innovation Mentors, a consortium of top universities which provides commercialization mentoring to faculty and MATTER, the city's healthcare tech incubator that John cofounded in Chicago's Merchandise Mart. John has successfully raised over $370 million of both private and philanthropic capital to fund the development of these impactful organizations. Prior to Founding Portal Innovations and co-founding Pyxis Oncology, John led the University of Chicago's Polsky Center for Entrepreneurship and Innovation, which supports faculty and students through education, venture creation and commercialization of inventions across campus and at three affiliates: Argonne National Laboratory, Fermilab and the Marine Biological Laboratory. In this role he helped establish strategic partnerships including University of Illinois, Army Research Laboratory, Wexford Science & Technology and AbbVie and assisted in raising over $150 million in philanthropic sponsorships including the Duchossois Family Institute and the Polsky Center gifts.John has won numerous awards related to his work in innovation and entrepreneurship including Crain's Who's Who in Business and Crain's Tech 50. He is a member of Governor Rauner's Innovation Council and Mayor Emanuel's ChicagoNEXT tech council.
-
Founder And CeoPortal Innovations, LlcChicago, Il, Us -
Founder & CeoPortal Innovations, Llc Mar 2020 - PresentChicago, Illinois, Us -
Chairman And Co-FounderPyxis Oncology May 2018 - PresentBoston, Ma, UsPyxis Oncology is an immuno-oncology company focused on developing novel therapies to help patients defeat difficult to treat cancers. Built on the ground-breaking research of Dr. Thomas Gajewski, Pyxis is pursuing promising novel targets derived from the latest insights into the tumor microenvironment. Pyxis has generated preclinical data on these targets and is developing a pipeline of novel antibodies with the potential to help new patient populations not currently served by today’s immunotherapies. -
Executive ChairmanClostrabio, Inc Mar 2020 - PresentChicago, Il, UsClostraBio is dedicated to understanding and treating food allergies and other diseases of the immune system. -
Entrepreneurial AdvisorArgonne National Laboratory Oct 2014 - PresentLemont, Il, UsJoint staff position between Argonne and University of Chicago to support entrepreneurial and commercialization activities within the Lab. -
Managing DirectorFlavin Ventures, Llc May 2002 - PresentA venture creation and management firm focused on life sciences company formation and development. -
Guest Lecturer - Entrepreneurial Finance/Commercializing InnovationUniversity Of Chicago Booth School Of Business Jan 2006 - PresentChicago, Illinois, Us -
Senior AdvisorUniversity Of Chicago May 2018 - Mar 2020Chicago, Il, UsThe Polsky Center helps innovators and entrepreneurs from the University of Chicago, its National Lab affiliates and the community to bridge the gap between knowledge and practice, idea and action, and research and impact through education and the creation of new ventures and commercial partnerships. The Polsky Center supports all University of Chicago innovation and entrepreneurship educational programming, technology licensing, commercialization and industrial relations activities. -
Associate Vice President Of Entrepreneurship And Innovation, HeadUniversity Of Chicago Jul 2016 - May 2018Chicago, Il, Us -
Founding Executive DirectorUniversity Of Chicago Oct 2013 - May 2018Chicago, Il, UsA start-up and commercialization hub supporting faculty, students and local entrepreneurs by providing co-working and incubator space, programming and connections to venture capitalists, strategic services and corporate partners. The CIE partners with several groups within the University of Chicago, Argonne, Fermi and Marine Biological Laboratory including the Polsky Center for Entrepreneurship and Innovation, UChicagoTech and several others. The CIE also manages the UChicago $20 million Innovation Fund. -
Chief Financial OfficerEndotronix, Inc. May 2018 - Mar 2020Naperville, Illinois, UsEndotronix is developing an integrated platform to provide comprehensive, reimbursable health management innovations for patients suffering from advanced heart failure. The company’s solution, the Cordella™ Heart Failure System, includes a cloud-based disease management data system and at home hemodynamic management with a breakthrough implantable wireless pulmonary artery pressure sensor for early detection of worsening heart failure. -
Cofounder/Executive DirMatter/Chicago Innovation Mentors Oct 2011 - Sep 2013Chicago, Illinois, UsA consortium of the University of Chicago, Northwestern University, the University of Illinois, iBIO/Propel, Argonne National Laboratory, Northern Illinois University and Rehabilitation Institute of Chicago focused on commercializing complex technology innovation and entrepreneurship. Cofounded and combined CIM into MATTER, Chicago's health and biotech innovation hub. -
President, Cfo, Co-Founder And Board DirectorAdvanced Life Sciences Jun 2002 - May 2011Us(NASDAQ: ADLS 2005 IPO) A public biotech company focused on the development of drugs in the therapeutic areas of infection, cancer and respiratory diseases. -
Chief Operating Officer, Board DirectorMedichem Life Sciences May 1990 - May 2002(NASDAQ: MCLS 2000 IPO) A public drug discovery technology and services company focused on a medicinal chemistry and structural biology platform. (Sold to deCODE genetics, Inc. NASDAQ: DCGN in 2002 later sold to Amgen, Inc. NASDAQ: AMGN)
John Flavin Skills
John Flavin Education Details
-
Marquette UniversityFinance -
Lewis UniversityFinance -
Benet Academy
Frequently Asked Questions about John Flavin
What company does John Flavin work for?
John Flavin works for Portal Innovations, Llc
What is John Flavin's role at the current company?
John Flavin's current role is Founder and CEO.
What is John Flavin's email address?
John Flavin's email address is jf****@****ago.edu
What is John Flavin's direct phone number?
John Flavin's direct phone number is +163029*****
What schools did John Flavin attend?
John Flavin attended Marquette University, Lewis University, Benet Academy.
What skills is John Flavin known for?
John Flavin has skills like Strategic Partnerships, Executive Management, Mergers, M&a, Angel Investing, Start Ups, Portfolio Management, Financial Modeling, Biotechnology, Business Development, Market Research, Competitive Analysis.
Who are John Flavin's colleagues?
John Flavin's colleagues are Rose Jones-Boyd, Robert H. Miller, Jieun Kwon, Harry Gerard, Karol Sokolowski, Elizabeth Harney, Tim Flavin.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial